Morriston Hospital team's blood clot warfarin findings

Professor Adrian Evans Prof Evans hopes for a wider study into blood clots

Related Stories

A research team at a casualty unit says some patients may still be at risk of blood clots, despite receiving the anticoagulant drug warfarin.

The team at Swansea's Morriston Hospital hopes its findings, to be published soon, will lead to a wider study to identify patients who are unlikely to respond to treatment.

The unit was formed to identify patients at risk of fatal blood clots.

Professor Adrian Evans, leading the study, said findings were "promising".

The research is being conducted by the hospital's NISCHR Haemostasis Biomedical Research Unit.

It has 340 patients involved in studies researching sepsis, strokes, heart disease, cancer and thromboprophylaxis - the practice of giving small doses of anticoagulant drugs to people at risk of deep vein thrombosis.

Start Quote

It is early days yet but the research so far looks promising and more work needs to be done”

End Quote Prof Adrian Evans Morriston Hospital, Swansea

On the warfarin findings, Prof Evans, professor of emergency medicine and haemostasis, said: "This may help us identify which patients are likely to have recurrence despite being on anti coagulant therapy.

"We hope that if this is the case - and this will require a much bigger study supported by this evidence - then we will be able to look at different treatment options to protect these patients."

The unit said a recent report showed 70% of deaths from clots acquired in hospitals could have been avoided.

In 2010, 900 people in Wales died from deep vein blood clots they developed in hospital, it said.

Prof Evans added: "We have a long way to go but we are making inroads into our understanding of why certain illnesses form early and abnormal blood clots which can break off and lodge in other organs causing complications and even death.

"We are particularly focusing on those diseases where clot developments are known to occur, such as acute cardio respiratory disease, stroke, trauma and cancer.

"It is early days yet but the research so far looks promising and more work needs to be done."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

BBC South West Wales



9 °C 7 °C

Features & Analysis

Elsewhere on the BBC

  • Audi R8Best in show

    BBC Autos takes a look at 10 of the most eye-catching new cars at the 2015 Geneva motor show


  • A robotClick Watch

    The latest in robotics including software that can design electronics to solve problems

Try our new site and tell us what you think. Learn more
Take me there

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.